Table of Services

Population Studies Publications

2012

  • Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiol Biomarkers Prev. 2012; 21(1):53-60.
  • Russo J, Santucci-Pereira J, de Cicco RL, Sheriff F, Russo PA, Peri S, Slifker M, Ross E, Mello ML, Vidal BC, Belitskaya-Lévy I, Arslan A, Zeleniuch-Jacquotte A, Bordas P, Lenner P, Ahman J, Afanasyeva Y, Hallmans G, Toniolo P, Russo IH. Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. Int J Cancer. 2012; 131(5):1059-70.

2011

  • Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, Tapia C, Kim H, Smitha Y, Sharma C, Nicolas E, Balagurunathanb Y, Ross EA, Jordan VC. Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer via stress responses as identified by global gene expression Proc Natl Acad Sci. 2011; 108(47):18879-86.
  • Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Russo J, Russo IH, Bordás P, Ahman J, Afanasyeva Y, Johansson R, Lenner P, Li X, de Cicco RL, Peri S, Ross E, Russo PA, Santucci-Pereira J, Sheriff FS, Slifker M, Hallmans G, Toniolo P, Arslan AA. Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res (Phila), 2011; 4(9):1457-64.
  • Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude J, Chanock SJ, Chasman DI, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, Dimopoulos AM, Driver WR, Dünnebier T, Durcan L, Eccles D, Edlund CK, Ekici AB, Fasching PA, Feigelson HS, Flesch-Janys D, Fostira F, Försti A, Fountzilas G, Gerty SM, The Gene Environment Interaction and Breast Cancer in Germany (GENICA) Consortium, Giles GG, Godwin AK, Goodfellow P, Graham N, Greco D, Hamann U, Hankinson SE, Hartmann A, Hein R, Heinz J, Holbrook A, Hoover RN, Hu JJ, Hunter DJ, Ingles SA, Irwanto A, Ivanovich J, John EM, Johnson N, Jukkola-Vuorinen A, Kaaks R, Ko YD, Kolonel LN, Konstantopoulou I, Kosma VM, Kulkarni S, Lambrechts D, Lee AM, Marchand LL, Lesnick T, Liu J, Lindstrom S, Mannermaa A, Margolin S, Martin NG, Miron P, Montgomery GW, Nevanlinna H, Nickels S, Nyante S, Olswold C, Palmer J, Pathak H, Pectasides D, Perou CM, Peto J, Pharoah PD, Pooler LC, Press MF, Pylkäs K, Rebbeck TR, Rodriguez-Gil JL, Rosenberg L, Ross E, Rüdiger T, Silva ID, Sawyer E, Schmidt MK, Schulz-Wendtland R, Schumacher F, Severi G, Sheng X, Signorello LB, Sinn HP, Stevens KN, Southey MC, Tapper WJ, Tomlinson I, Hogervorst FB, Wauters E, Weaver J, Wildiers H, Winqvist R, Berg DV, Wan P, Xia LY, Yannoukakos D, Zheng W, Ziegler RG, Siddiq A, Slager SL, Stram DO, Easton D, Kraft P, Henderson BE, Couch FJ. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature Genetics. 2011; 43(12):1210-14.
  • O’Grady M, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ. Assessing compliance with National Comprehensive Cancer Network Guidelines for elderly patients with stage iii colon cancer: The Fox Chase Cancer Center Partners’ Initiative. Clin Colorectal Cancer. 2011; 10(2) 113-16.
  • Patel RR, Li T, Ross EA, Sesa L, Sigurdson ER, Bleicher RJ. The effect of simultaneous peripheral excision in breast conservation upon margin status. Ann Surg Oncol. 2011; 17(11):2933-39.
  • Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H, Schmidt MK, Cox A, Cross SS, Sawyer E, Hartmann A, Beckmann MW, Schulz-Wendtland R, Ekici AB, Tapper WJ, Gerty SM, Durcan L, Graham N, Hein R, Nickels S, Flesch-Janys D, Heinz J, Sinn HP, Konstantopoulou I, Fostira F, Pectasides D, Dimopoulos AM, Fountzilas G, Clarke CL, Balleine R, Olson JE, Fredericksen Z, Diasio RB, Pathak HB, Ross E, Weaver J, Rüdiger T, Försti A, Dünnebier T, Ademuyiwa F, Kulkarni S, Pylkäs K, Jukkola-Vuorinen A, Ko YD, Van Limbergen E, Janssen H, Peto J, Fletcher O, Giles GG, Baglietto L, Verhoef S, Tomlinson I, Kosma VM, Beesley J, Greco D, Blomqvist C, Irwanto A, Liu J, Blows FM, Dawson SJ, Margolin S, Mannermaa A, Martin NG, Montgomery GW, Lambrechts D, Dos Santos Silva I, Severi G, Hamann U, Pharoah P, Easton DF, Chang-Claude J, Yannoukakos D, Nevanlinna H, Wang X, Couch FJ. Common breast cancer susceptibility loci are associated with triple negative breast cancer. Cancer Res. 2011; 71(19):6240-49.

2010

  • Bellacosa A Godwin AK Peri S Devarajan K Caretti E Vanderveer L Bove B Slater C Zhou Y Daly M Howard S Campbell KS Nicolas E Yeung AT Clapper ML Crowell JA Lynch HT Ross E Kopelovich L Knudson AG Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations Cancer. Prev Res. 2010;3:48-61.
  • Giri VN, Ruth K, Hughes L, Uzzo RG, Chen DYT, Boorjian SA, Viterbo R, Rebbeck TR. Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: Effect of TMPRSS2 Met160Val BJU Int. Forthcoming 2010
  • Kaplan DJ, Boorjian SA, Ruth K, Egleston BL, Chen DY, Viterbo R, Uzzo RG, Buyyounouski MK, Raysor S, Giri VN. Evaluation of the prostate cancer prevention trial risk calculator in high-risk Screening population. BJU Int. 2010; 105:334-37.
  • Manne S, Badr H, Zaider T, Nelson C, Kissane D, Cancer-related communication relationship intimacy and psychological distress among couples coping with localized prostate cancer. Cancer Surviv. 2010 4:74-85.
  • Manne S, Winkel G, Zaider T, Rubin S, Hernandez E, Bergman C. Therapy processes and outcomes of psychological interventions for women diagnosed with gynecological cancers: A test of the generic process model of psychotherapy. J Consult Clin Psychol. 2010; 78:236-48.
  • Manne SL, Meropol NJ, Weinberg DS, Vig H, Catts ZA-K, Manning C, Ross E, Shannon K, Chung D. Facilitating informed decision regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol. 2010; 28:1366-72.
  • Patel RR, Sengupta S, Kim HR, Klein-Szanto AJ, Pyle JR, Zhu F, Li T, Ross EA, Oseni S, Fargnoli J, Jordan VC. Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate a VEGFR-2/FGFR-1 kinase inhibitor: A potential clinical application of angiogenesis inhibitors. Eur J Cancer. 2010;46:1537-53.
  • Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A, Ross E, Godwin A. Enhanced counselling for women undergoing BRCA1/2 testing: impact on knowledge and psychological distress - results from a randomised clinical trial. Psychol Health. 2010;25:401-15.
  • Scoll BJ, Uzzo RG, Chen DY, Boorjian SA, Kutikov A, Manley BJ, Viterbo R. Robot-assisted partial nephrectomy: a large single-institutional experience. Urology. 2010;75:1328-34.

2009

  • Fang CY, Cherry C, Devarajan K, Li T, Malick J, Daly MB. A prospective study of quality of life among women undergoing risk-reducing salpingo-ophorectomy versus gynecologic screening for ovarian cancer. Gynecol Oncol. 2009; 112:594-600.
  • Giri V, Egleston BL, Ruth K, Uzzo RG, Chen DYT, Buyyounouski M, Raysor S, Hooker S. Race genetic West African ancestry and prostate cancer prediction by PSA in prospectively screened high-risk men. Cancer Prev Res. 2009; 2:244-50.
  • Giri VN, Coups EJ, Ruth K, Goplerud J, Raysor S, Kim TY, Bagden L, Mastalski K, Zakrzewski D, Leimkuhler S, Watkins-Bruner D. Prostate cancer early detection program recruitment methods and show rates in men at high risk. J Urol. 2009; 182:2212-17.
  • Manne SL, Coups EJ, Winkel G, Markowitz A, Meropol NJ, Lesko SM, Jacobsen PB, Haller D, Jandorf L, Peterson SK. Identifying cluster subtypes for Iintentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer. Health Educ Res. 2009; 24:897-08.
  • Min H, Manion FJ, Goralczyke E, Wong YN, Ross E, Beck JR. Integration of prostate cancer clinical data using an ontology. J Biomed Inform. 2009; 42:1035-45.
  • Qian Y, Tchuvatkina O, Spidlen J, Wilkinson P, Gasparetto M, Jones AR, Manion FJ, Scheuermann RH, Sekaly RP, Brinkman RR. FuGEFlow: data model and markup language for flow cytometry BMC Bioinformatics. 2009; 10:184-90.
  • Rhodes J, Amsterdam A, Sanda T, Moreau LA, McKenna K, Heinrichs S, Ganem NJ, Ho KW, Neuberg DS, Johnson A, Ahn Y, Kotok JL, Hromas R, Wray J, Lee C, Murphy C, Radke I, Downing JR, Fleming MD, Macconaill LE, Amatruda JF, Gutierrez A, Galinsky I, Stone RM, Ross EA, Pellman DS, Kanki JP, Look AT. Emi1 maintains genomic integrity during Zebrafish embryogenesis and cooperates with p53 in tumor suppression. Mol Cell Biol. 2009; 29:5911-22.
  • Schilder RJ, Pathak HB, Lokshin A, Holloway RW, Alvarez RD, Aghajanian C, Min H, Devarajan K, Ross E, Drescher CW, Godwin AK. Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecol Oncol. 2009;113:21-27.

2008

  • Abramowitz MC Li T Buyyounouski MK Ross E Uzzo RG Pollack A Horowitz EM The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008; 112(1):55-60.
  • Antoniou AC, Spurdle AB, Sinilnikova OM, Healy S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deisler H, Caldes T, Kämpjärvi K, Nevanlinna H, Simard J, Beesley J, Chen X, the Kathleen Cunningham Consortium for Research into Familial Breast Cancer, Neuhausen SL, Rebbeck TR, Wagner T, Lynch HT, Isaacs C, Weitzel J, Ganz PA, Daly MB, Tomlinson G, Olopade OI, Blum JL, Couch FJ, Peterlongo P, Manoukian S, Barile M, Radice P, Szabo CI, Mateus Pereira LH, Greene MH, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis I, Ozcelik H, OCGN, Gerdes AM, Caligo MA, Laitman Y, Kaufmann B, Milgrom R, Friedman E, SWE-BRCA, Domchek SM, Nathanson KL, Osorio A, Llort G, Milne RL, Benitez J, Hamann U, Hogervorst FBL, Rookus MA, Manders P, Ligtenberg MJL, van den Ouweland AMW, Peock S, Cook M, Platte R, Evans DG, Eeles R, Pichert G, Chu C, Eccles D, Davidson R, Douglas F, EMBRACE, Godwin AK, Barjhoux L, Mazoyer S, Sobol H, Bourdon V, Eisinger F, Chompret A, Capoulade C, Bressac-de-Paillerets B, Lenoir GM, Gauthier-Villars M, Houdayer C, Stoppa-Lyonnet D, Chenevix-Trench G, Easton DF, CIMBA Common breast cancer predisposition alleles modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet. 2008; 82:937-48.
  • Barsevick AM Montgomery SV Ruth K Ross EA Egleston BL Bingler R Malick J Miller SM Cescon TP Daly MB Intention to communicate BRCA1/BRCA2 genetic test results to the family. J Fam Psychol. 2008; 22:303-12.
  • Bleicher R O'Sullivan M Ciocca R Ciocca V Perkins LA Ross E Li T Patchefsky A Sigurdson ER Joseph N Sesa L Morrow M A prospective feasibility trial to determine the significance of the sentinel node gradient in breast cancer: A predictor of nodal metastasis location. Cancer. 2008;113:3100-07.
  • Caretti E Devarajan K Coudry R Ross E Clapper ML Cooper HS Bellacosa A Comparison of RNA amplification methods and chip platforms for microarray analysis of samples processed by laser capture microdissection. J Cell Biochem. 2008; 103:556-63.
  • Ciocca RM, Li T, Freedman GM, Morrow M. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol. 2008; 15:2263-71.
  • Collins M Ross E "Survey Domain Model: A Population Science SIG Report" a caBIGTM Whitepaper February 2008 http://gforgencinihgov/docmar/viewphp/194/11066/ FCCCSurveyModel_White_Paperpdf).
  • Conrad P, Crowell JA, Kopelovich L, Knudson A. One-hit effects in cancer: Altered proteome of morphologically normal colon crypts in Familial Adenomatous Polyposis. Cancer Res. 2008; 68:7579-86.
  • D'Ambrosio DJ, Li T, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does treatment duration affect outcome after radiotherapy for prostate cancer? Int J Radiat Oncol Biol Phys. 2008; 72:1402-07.
  • D'Ambrosio DJ, Ruth K, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer? Urology. 2008;71:938-41.
  • D'Ambrosio DJ, Ruth K, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier? Int J Radiat Oncol Biol Phys. 2008;70:1489-91.
  • Ding Y, Larson G, Rivas G, Lundberg C, Geller L, Ouyang C, Weitzel J, Archambeau J, Slater J, Daly MB, Benson AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Nordborg M, Krontiris TG. Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk. PLoS ONE. 2008; 3:e3533.
  • Eade TN, Horwitz EM, Ruth K, Buyyounouski MK, D'Ambrosio DJ, Feigenberg SJ, Chen DY, Pollack A. A comparison of acute and chronic toxicity for men and low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant. Int J Radiat Oncol Biol Phys. 2008;71:338-45.
  • Eisen A, Lubinski J, Gronwald J, Moller P, Lynch HT, Klijn J, Kim-Sing C, Neuhausen SL, Gilbert L, Ghadirian P, Manoukian S, Rennert G, Friedman E, Isaacs C, Rosen E, Rosen B, Daly M, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst. 2008;100:1341-43.
  • Fang CY, Miller SM, Bovbjerg DH, Bergman C, Edelson MI, Rosenblum NG, Bove BA, Godwin AK, Campbell DE, Douglas SD. Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia. Ann Behav Med 2008;35:87-96.
  • Fleisher L, Buzaglo J, Collins M, Millard J, Miller SM, Egleston BL, Solarino S, Trinastic J, Cegala DJ, Benson AB III, Schulman KA, Weinfurt KP, Sulmasy D, Diefenbach MA, Meropol NJ. Using Health communication best practices to develop a web-based provider-patient communication aid: the CONNECTTM study. Patient Educ Couns. 2008;71:378-87.
  • Fu J, Fong K, Bellacosa A, Ross E, Apostolou S, Bassi DE, Jin F, Zhang J, Cairns P. VILIP-1/ downregulation in non-small cell lung carcinomas: Mechanisms and prediction of survival. PLos One2008; 3:e1698.
  • Haile R, Daly M, Godwin A, Ross E, Beck J, Terry MB, Buys SS, Whittemore AS, John EM, Felberg A, McGuire V, West DW, Miron A, Thomas DC. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Res Treat. 2008; 109:67-75.
  • Hayes SB, Freedman GM, Li T, Anderson PR, Ross E. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys. 2008; 72:1449-55.
  • Huang Y, Collins MA, Ross EA, Beck JR. Usability test of a family health history web tool. AMIA Annu Symp Proc. 2008; 981.
  • Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, Neuhausen SL, Daly MB, Matloff E, Blum JL, Sabbatini P, Barakat RR, Hudis C, Norton L, Offit K, Rebbeck TR, Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter prospective study. J Clin Oncol. 2008; 26:1331-37.
  • Lee JA, Spidlen J, Boyce K, Cai J, Crosbie N, Dalphin M, Furlong J, Gasparetto M, Goldberg M, Goralczyk EM, Hyun B, Jansen K, Kollmann T, Kong M, Leif R, McWeeney S, Moloshok TD, Moore W, Nolan G, Nolan J, Nikolich-Zugich J, Parrish D, Purcell B, Qian Y, Selvaraj B, Smith C, Tchuvatkina O, Wertheimer A, Wilkinson P, Wilson C, Wood J, Zigon R, International Society for Advancement of Cytometry Data Standards Task Force, Scheuermann RH, Brinkman RR, MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A. 2008; 73:926-30.
  • Lessin SR, Ross EA, Wu H. Treatment of parapsoriasis with Bexarotene 1% Gel Internatl J Dermatol. 2008; 47:1325-27.
  • Manne S, Rini C, Rubin S, Rosenblum N, Bergman C, Edelson M, Hernandez E, Carlson J, Rocereto T. Long-term trajectories of psychological adaptation among women diagnosed with gynecological cancers. Psychosom Med. 2008; 70:677-87.
  • Manne SL, Winkel G, Rubin S, Edelson M, Rosenblum N, Bergman C, Hernandez E, Carlson J, Rocereto T. Mediators of a coping and communication-enhancing intervention and a supportive counseling intervention among women diagnosed with gynecological cancers. J Consult Clin Psychol. 2008; 76:1034-45.
  • Masny A, Ropka M, Peterson C, Fetzer D, Daly MB. Mentoring nurses in familial cancer risk assessment and counseling: lessons learned from a formative evaluation. J Genet Counsel. 2008; 17:196-07.
  • Mastalski K, Coups EJ, Ruth K, Raysor S, Giri VN. Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program. Cancer. 2008; 113:2559-64.
  • Meropol NJ, Egleston BL, Buzaglo JS, Benson AB, Cegala DJ, Diefenbach MA, Fleisher L, Miller SM, Sulmasy DP, Weinfurt KP, CONNECT Study Research Group. Cancer patient preferences for quality and length of life. Cancer. 2008; 113:3459-66.
  • Meropol NJ, Egleston BL, Buzaglo JS, Benson AB, Cegala DJ, Diefenbach MA, Fleisher L, Miller SM, Sulmasy DP, Weinfurt KP, CONNECT Study Research Group, The CONNECT Study Research Group includes: Balshem A, Micco E, Millard JL, Ross EA, Schulman KA, Slater E, Solarino N, Trinastic J. Cancer patient preferences for quality and length of life. Cancer. 2008; 113:3459-66.

2007

  • Apicella C, Dowty JG, Dite GS, Jenkins MA, Senie RT, Daly MB, Andrulis IL, John EM, Buys SS, Li FP, Glendon G, Chung W, Ozcelik H, Miron A, Kotar K, Southey MC, Foulkes WD, Hopper JL. Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish Women. Clin Genet. 2007;72:87-97.
  • Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hibshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O'Malley FP for the Breast Cancer Family Registry. BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol. 2007;31:121-28.
  • Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PO, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Marchand LL, Henderson BE, Atlshuler D, Haber DA, Freedman ML. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer. 2007;121:2661-67.
  • Buzaglo JS Millard JL Ridgway CG Ross EA Antaramian SP Miller SM Meropol NJ An internet method to assess cancer patient information needs and enhance doctor-patient communication: A Pilot Study J Cancer Educ. 2007;22:233-40.
  • Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, Porteous ME, Jakubowska A, Lubinski J, Gronwald J, Spurdle AB, kConFab, Schmutzler R, Versmold B, Engel C, Meindl A, Sutter C, Horst J, Schaefer D, Offit K, Kirchhoff T, Andrulis IL, Ilyushik E, Glendon G, Devilee P, Vreeswijk MP, Vasen HF, Borg A, Backenhorn K, Struewing JP, Greene MH, Neuhausen SL, Rebbeck TR, Nathanson K, Domchek S, Wagner T, Garber JE, Szabo C, Zikan M, Foretova L, Olson JE, Sellers TA, Lindor N, Nevanlinna H, Tommiska J, Aittomaki K, Hamann U, Rashid MU, Torres D, Simard J, Durocher F, Guenard F, Lynch HT, Isaacs C, Weitzel J, Olopade OI, Narod S, Daly MB, Godwin AK, Tomlinson G, Easton DF, Chenevix-Trench G, Antoniou AC, on behalf of the Consortium of Investigators of Modifiers of BRCA1/2. AURKA F311 polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev. 2007; 16:1416-21.
  • Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR. Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. Clin Breast Cancer. 2007;7:875-82.
  • Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG, Hanks G, Godwin AK, Chen DY, Gordon R, Cescon T, Raysor S, Watkins-Brunner D. Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol. 2007;178:1920-24.
  • Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13:1736-41.
  • Henry LR, Sigurdson E, Ross EA, Lee JS, Watson JC, Cheng JD, Freedman GM, Konski A, Hoffman JP. Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcome. Surg Oncol. 2007;7:2000-09.
  • Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev. 2007;16:912-16.
  • Kotsopoulos J, Lubinski J, Lynch TH, Klign J, Ghadirian P, Neuhausen SL, Kim-Sing C, Foulkes WD, Moller P, Isaacs C, Domchek S, Randall S, Offit K, Tung N, Ainsworth P, Gershoni-Barush R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T, Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA. The Hereditary Breast Cancer Clinical Study Group Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2007;105:221-28.
  • Manne SL, Chung DC, Weinberg DS, Vig HS, Catts Z, Cabra MK, Shannon K, Meropol NJ. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2110-17.
  • Meropol NJ, Buzaglo JS, Millard J, Damjanov N, Miller SM, Ridgway C, RossEA, Sprandio JD, Watts P. Barriers to clinical trial participation as perceived by oncologists and patients. Natl Compr Canc Netw. 2007;5:655-64.
  • O'Grady MA, Gitelson E, Swaby RF, Goldstein LJ, Sein E, Keeley P, Miller B, Li T, Weinstein A, Cohen SJ. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: the Fox Chase Cancer Center Partners initiative. J Natl Compr Canc Netw. 2007;5:875-82.
  • Page RE, Klein-Szanto AJP, Litwin S, Nicolas E, Al-Jumaily R, Alexander P, Godwin AK, Ross EA, Schilder RJ, Bassi DE. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol. 2007;29:289-99.
  • Patel AA, Gilbertson JR, Showe LC, London JW, Ross E, Ochs MF, Carver J, Lazarus A, Parwani AV, Dhir R, Beck JR, Liebman M, Garcia FU, Prichard J, Wilkerson M, Herberman RB, Becich MJ, the PCABC. A novel cross-disciplinary multi-institute approach to translational cancer research: Lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform. 2007;3:255-74.
  • Patel BB, Li XM, Dixon MP, Blagoi EL, Seeholzer SH, Chen Y, Miller CG, He YA, Tetruashvily M, Chaudhry AH, Ke E, Xie J, Cooper H, Bellacosa A, Clapper ML, Boman BM, Zhang T, Litwin S, Ross E, Conrad P, Crowell JA, Kopelovich L, Knudson A, Yeung AT. Searchable high resolution 2D gel proteome of the human colon crypt J Proteome Res 2007;6:2232-38.
  • Tchou J, Ward MR, Volpe P, Palma MD, Medina CA, Sargen M, Sonnad SS, Godwin AK, Daly M, Winchester DJ, Garber J, Weber BL, Domchek S, Nathanson KL. Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clin Breast Cancer. 2007; 7:627-33.
  • Terry MB, Knight JA, Zablotska L, Wang Q, John EM, Andrulis IL, Senie RT, Daly M, Ozcelik H, Briollais L, Santella RM. Alcohol metabolism alcohol intake and breast cancer risk: a sister-set analysis using the Breast Cancer Family Registry. Br Cancer Res Treat. 2007; 106:281-88.
  • Tseng M, Byrne C, Evers KA, Daly MB. Dietary intake and breast density in high-risk women: a cross-sectional study. Br Cancer Res. 2007; 9:R72.
  • Tseng M, Olufade T, Kurzer M, Wahala K, Fang CY, van der Schouw Y, Daly MB. Food frequency questionnaires and overnight urines are valid indicators of daidzein and genistein intake in US women relative to multiple 24-hour urine samples. Nutr Cancer. 2008; 60:619-26.
  • Yeung AT, Patel BB, Li XM, Seeholzer SH, Coudry RA, Cooper HS, Bellacosa A, Boman BM, Zhang T, Litwin S, Ross EA, Conrad P, Crowell JA, Kopelovich L, Knudson A. One-hit effects in cancer: Altered proteome of morphologically normal colon crypts in Familial Adenomatous Polyposis. Cancer Res. 2008; 68:7579-86.

2006

  • Alcántara, P, Hanlon AL, Buyyounouski MK, Horwitz EM, Pollack A. PSA nadir within 12 months of prostate cancer radiotherapy predicts for metastasis and death. Cancer. 2006;109:41-47.
  • Balogh GA, Heulings R, Mailo DA, Russo PA, Sheriff F, Russo IH, Moral R, Russo J. Genomic signature induced by pregnancy in the human breast. Int J Oncol. 2006;28:399-410.
  • Berg WA Weinberg IN Narayanan D Lobrano ME Ross E Amodei L Tafra L Adler LP Uddo J Stein W 3rd Levine EA Positron Emission Mammography Working Group High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J. 2006;12:309-23.
  • Fang CY, Daly MB, Miller SM, Zerr T, Malick JD, Engstrom PF. Coping with ovarian cancer risk: the moderating effects of perceived control on coping and adjustment. Br J Health Psychol. 2006;11:561-80.
  • Freedman GM, Anderson P, Li T, Ross E, Swaby R, Goldstein L. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen Cancer 2006;107:2552-58.
  • Konski A, Eisenberg D, Horwitz E, Hanlon A, Pollack A, Hanks GE. Does age matter in the selection of treatment for men with early-stage prostate cancer? Cancer. 2006; 106:2598-02.
  • Konski A, Watkins-Bruner D, Feigenberg S, Hanlon A, Kulkarni S, Beck JR, Horwitz EM, Pollack A. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys. 2006; 66:408-15.
  • Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma C-MC, McNeeley SW, Buyyounouski MK, Price RA. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys. 2006; 64:518-26.
  • Price RA, Hannoun-Levi J-M, Horwitz EM, Buyyounouski MK, Ruth KJ, Ma C M, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2006;66:583-92.
  • Ross EA, Collins M. caDSR Enablement of PRESAGE" a caBIGTM Whitepaper March 2006; https://gforgencinihgov/docman/viewphp/189/6555/caDSR_Enablement PRESAGE_Finalpdf.
  • Russo J, Balogh GA, Chen J, Fernandez SV, Fernbaugh R, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff FA, Vanegas JE, Wang R, Russo IH. The concept of stem cell in the mammary gland and its implication in morphogenesis cancer and prevention. Front Biosci. 2006; 11:151-72.
  • Russo J, Balogh GA, Heulings R, Mailo DA, Moral R, Russo PA, Sheriff F, Vanegas J, Russo IH. Molecular basis of pregnancy induced breast cancer protection. Eur J Cancer Prev. 2006;15:306-42.
  • Tseng M, Byrne C, Evers KA, London WT, Daly MB. Acculturation and breast density in foreign-born US Chinese women. Cancer Epidemiol Biomarkers Prev. 2006; 15:1301-05.

2005

  • Andrews SF, Horwitz EM, Feigenberg SJ, Eisenberg DF, Hanlon AL, Uzzo RG, Pollack A. Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma? Cancer. 2005;104:299-04.
  • Baffoe-Bonnie AB, Smith JR, Stephan DA, Schleutker J, Carpten JD, Kainu T, Gillanders EM, Matikainen MP, Teslovich TM, Tammela TLJ, Sood R, Balshem AM, Scarborough SD, Xu J, Isaacs WB, Trent JM, Kallioniemi O-P, Bailey-Wilson, JE. A major locus for hereditary prostate cancer in Finland: localization by linkage disequilibrium of a haplotype in the HPCX Region. Hum Genet. 2005;17:307-16.
  • Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A. Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys. 2005;63:1455-62.
  • Buyyounouski MK, Hanlon AL, Horwitz EM, Uzzo RG, Pollack A. Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. Int J Radiat Oncol Biol Phys. 2005; 61:1291-98.
  • Fang CY, Tseng M, Daly MB. Correlates of soy food consumption in women at increased risk for breast cancer. J Am Diet Assoc. 2005;105:1552-58.
  • Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg DF, Pollack A. What pretreatment prostate-specific antigen level warrants long-term androgen deprivation? Int J Radiat Oncol Biol Phys. 2005;61:1003-10.
  • Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg D, Pollack A. Long-term androgen deprivation increases grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:397-405.
  • Henry LR, Sigurdson E, Ross E, Hoffman J. Hydronephrosis does not preclude curative resection of pelvic recurrences after colorectal surgery. Ann Surg Oncol. 2005; 12:786-92.
  • Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph-node involvement. Int J Radiat Oncol Biol Phys. 2005; 61:695-701.
  • Lewis JS, Meeke K, Osipo C, Ross EA, Kidawi N, Li T, Bell E, Chandel NS, Jordan VC. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst. 2005; 97:1746-59.
  • Miller SM, Fleisher L, Roussi P, Buzaglo JS, Schnoll R, Slater E, Raysor S, Popa-Mabe M. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's Cancer Information Service. J Health Commun .2005; 10:119-36.
  • Miller SM, Roussi P, Daly MB, Buzaglo JS, Sherman K, Godwin AK, Balshem A, Atchison MD. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health Educ Behav. 2005; 32:654-67.
  • Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, Isaacs C, Olopade OI, Neuhausen SL, van't Veer L, Eeles R, Evans DG, Tomlinson G, Matloff E, Narod SA, Eisen A, Domchek S, Armstrong K, Weber BL. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol. 2005; 23:7804-10.
  • Schnoll RA, Wang H, Miller SM, Babb JS, Cornfeld MJ, Higman-Tofani S, Henigan-Peel T, Balshem A, Slater E, Ross E, Boyd CS, Engstrom PF. Change in worksite smoking behavior following cancer risk feedback intervention: a pilot study. Am J Health Behav. 2005; 29:215-27.
  • Tafra L, Cheng Z, Uddo J, Lobrano MB, Stein W, Berg WA, Levine E, Weinberg IN, Narayannan D, Ross E, Beylin D, Yarnall S, Keen R, Sawyer K, Van Geffen J, Freimanis RL, Staab E, Adler LP, Lovelace J, Shen P, Stewart J, Dolinsky S. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg. 2005; 190:628-32.
  • Tseng M, Breslow RA, Graubard BI, Ziegler RG. Dairy calcium and vitamin D intake and prostate cancer risk in the NHEFS cohort. Am J Clin Nutr. 2005; 81:1147-54.
  • Tseng M, Hernández T. Comparison of intakes of US Chinese Women based on food frequency and 24-hour recall data. J Am Diet Assoc. 2005; 105:1145-48.
  • Weinfurt KP, DePuy V, Castel LD, Sulmasy DP, Schulman KA, Meropol NJ. Understanding of an aggregate probability statement by patients who are offered participation in phase I clinical trials. Cancer. 2005; 103:140-47.